Also trades as: 0IIM.L (LSE) · $vol 0M
ESPR NASDAQ
Esperion Therapeutics, Inc.
1W: +15949.7%
1M: +1.3%
3M: +46.5%
YTD: -14.3%
1Y: +156.4%
3Y: +117.8%
5Y: -84.5%
$3.18
Last traded 2026-07-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$418M
Revenue
+61.1% YoY
$-7M
Net Income
+95.2% YoY
$-18M
Free Cash Flow
+81.9% YoY
56.8%
Gross Margin
-8.2%
Op. Margin
-31.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE2.0%
ROA-1.9%
ROIC75.1%
Valuation
P/E-131.4
P/B-2.6
EV/EBITDA27.0
Leverage
Debt/Equity-1.77
Current Ratio1.53
Interest Cov.0.9x
Quality Scores
Piotroski F4/9
Altman Z-2.85
Beneish M-1.91